{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:15:27Z","timestamp":1791504927344,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation (QA)","doi-asserted-by":"publisher","award":["12014\/12"],"award-info":[{"award-number":["12014\/12"]}],"id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12664-015-0604-1","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:53:04Z","timestamp":1446684784000},"page":"404-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?"],"prefix":"10.1007","volume":"34","author":[{"given":"Anil","family":"John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Al Kaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Doiphode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manik","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragesh","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafie","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moutaz","family":"Derbala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"604_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00042737-199701000-00002","volume":"9","author":"P Malfertheiner","year":"1997","unstructured":"Malfertheiner P, M\u00e9graud F, O\u2019Morain C, et al. Current European concepts in the management of Helicobacter pylori infection\u2014the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997;9:1\u20132.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"604_CR2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","volume":"61","author":"P Malfertheiner","year":"2012","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, et al. Management of Helicobacter pylori infection\u2014the Maastricht IV\/ Florence Consensus Report. Gut. 2012;61:646\u201364.","journal-title":"Gut"},{"key":"604_CR3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ije\/31.1.128","volume":"31","author":"LA Fischbach","year":"2002","unstructured":"Fischbach LA, Goodman KJ, Feldman M, Aragaki C. Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol. 2002;31:128\u201339.","journal-title":"Int J Epidemiol"},{"key":"604_CR4","doi-asserted-by":"crossref","unstructured":"Song M, Ang TL. Second and third line treatment options for Helicobacter pylori eradication. World J Gastroenterol. 2014;20:1517\u201328.","DOI":"10.3748\/wjg.v20.i6.1517"},{"key":"604_CR5","doi-asserted-by":"crossref","unstructured":"Ierardi E, Giorgio F, Losurdo G, Di Leo A, Principi M. How antibiotic resistances could change helicobacter pylori treatment: a matter of geography? World J Gastroenterol. 2013;19:8168\u201380.","DOI":"10.3748\/wjg.v19.i45.8168"},{"key":"604_CR6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/CMR.00033-06","volume":"20","author":"F Megraud","year":"2007","unstructured":"Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20:280\u2013322.","journal-title":"Clin Microbiol Rev"},{"key":"604_CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jac\/31.1.65","volume":"31","author":"G Cederbrant","year":"1993","unstructured":"Cederbrant G, Kahlmeter G, Ljungh A. The E test for antimicrobial susceptibility testing of Helicobacter pylori. J Antimicrob Chemother. 1993;31:65\u201371.","journal-title":"J Antimicrob Chemother"},{"key":"604_CR8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dkp003","volume":"63","author":"N Wueppenhorst","year":"2009","unstructured":"Wueppenhorst N, Stueger HP, Kist M, Glocker E. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany. J Antimicrob Chemother. 2009;63:648\u201353.","journal-title":"J Antimicrob Chemother"},{"key":"604_CR9","first-page":"409","volume":"19","author":"V Francesco De","year":"2010","unstructured":"De Francesco V, Giorgio F, Hassan C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis. 2010;19:409\u201314.","journal-title":"J Gastrointestin Liver Dis"},{"key":"604_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1523-5378.2009.00714.x","volume":"14","author":"N Horiki","year":"2009","unstructured":"Horiki N, Omata F, Uemura M, et al. Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter. 2009;14:86\u201390.","journal-title":"Helicobacter"},{"key":"604_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2036.2007.03386.x","volume":"26","author":"L Fischbach","year":"2007","unstructured":"Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther. 2007;26:343\u201357.","journal-title":"Aliment Pharmacol Ther"},{"key":"604_CR12","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1128\/AAC.41.12.2724","volume":"41","author":"A Occhialini","year":"1997","unstructured":"Occhialini A, Urdaci M, Doucet-Populaire F, B\u00e9b\u00e9ar CM, Lamouliatte H, M\u00e9graud F. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother. 1997;41:2724\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"604_CR13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","volume":"62","author":"F Megraud","year":"2013","unstructured":"Megraud F, Coenen S, Versporten A, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62:34\u201342.","journal-title":"Gut"},{"key":"604_CR14","first-page":"660","volume":"44","author":"V Francesco De","year":"2006","unstructured":"De Francesco V, Margiotta M, Zullo A, et al. Claritromycin resistance and Helicobacter pylori genotypes in Italy. J Microbiol. 2006;44:660\u20134.","journal-title":"J Microbiol"},{"key":"604_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(12)61579-7","volume":"381","author":"JM Liou","year":"2013","unstructured":"Liou JM, Chen CC, Chen MJ, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2013;381:205\u201313.","journal-title":"Lancet"},{"key":"604_CR16","doi-asserted-by":"crossref","unstructured":"Gisbert JP, Calvet X, O\u2019Connor A, M\u00e9graud F, O\u2019Morain CA. Sequential therapy for Helicobacter pylori eradication: a critical review. J Clin Gastroenterol. 2010;44:313\u201325.","DOI":"10.1097\/MCG.0b013e3181c8a1a3"},{"key":"604_CR17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/jgh.12397","volume":"28","author":"H Yoon","year":"2013","unstructured":"Yoon H, Lee DH, Kim N, et al. Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults? J Gastroenterol Hepatol. 2013;28:1801\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"604_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1523-5378.2009.00671.x","volume":"14","author":"AS Essa","year":"2009","unstructured":"Essa AS, Kramer JR, Graham DY, Treiber G. Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing \u2018concomitant therapy\u2019 versus triple therapy for helicobacter pylori eradication. Helicobacter. 2009;14:109\u201318.","journal-title":"Helicobacter"},{"key":"604_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/j.gastro.2012.03.043","volume":"143","author":"A Federico","year":"2012","unstructured":"Federico A, Nardone G, Gravina AG, et al. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. Gastroenterology. 2012;143:55\u201361.","journal-title":"Gastroenterology"},{"key":"604_CR20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","volume":"377","author":"P Malfertheiner","year":"2011","unstructured":"Malfertheiner P, Bazzoli F, Delchier JC, et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet. 2011;377:905\u201313.","journal-title":"Lancet"},{"key":"604_CR21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.cgh.2013.01.008","volume":"11","author":"X Liang","year":"2013","unstructured":"Liang X, Xu X, Zheng Q, et al. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study. Clin Gastroenterol Hepatol. 2013;11:802\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"604_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/hel.12085","volume":"19","author":"PI Hsu","year":"2014","unstructured":"Hsu PI, Chen WC, Tsay FW, et al. Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therap. Helicobacter. 2014;19:74\u20139.","journal-title":"Helicobacter"},{"key":"604_CR23","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/gutjnl-2013-306120","volume":"63","author":"KS Liu","year":"2014","unstructured":"Liu KS, Hung IF, Seto WK, et al. Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and second linetreatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial. Gut. 2014;63:1410\u20135.","journal-title":"Gut"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-015-0604-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-015-0604-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-015-0604-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T04:17:30Z","timestamp":1567311450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-015-0604-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1007\/s12664-015-0604-1","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}